Combination Immunotherapy and Radiotherapy Causes an Abscopal Treatment Response in a Mouse Model of Castration Resistant Prostate Cancer

Journal for ImmunoTherapy of Cancer- United Kingdom

doi 10.1186/s40425-019-0704-z

Full Text

Abstract

Available in

Date

Authors

Publisher

BMJ

Related search

The Treatment Patterns of Castration Resistant Prostate Cancer in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Mp52-01 Combination of Indomethacin and Enzalutamide to Treat Castration-Resistant Prostate Cancer

Journal of Urology
Urology
2018English

Treatment With Galeterone in an Elderly Man With Castration-Resistant Prostate Cancer: A Case Report

Clinical Genitourinary Cancer
OncologyUrology
2015English

Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients With Oligo-Progression During Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Visceral Disease in Castration-Resistant Prostate Cancer

European Urology
Urology
2014English

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Yearbook of Paediatric Endocrinology
2019English

Castration-Resistant Prostate Cancer: A Strategy to Enhance Response to Androgen Deprivation

Asian Journal of Andrology
MedicineUrology
2013English

Guideline Adherence in Docetaxel Treatment of Castration Resistant Prostate Cancer (CRPC) Patients in a Real-World Population: The Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy